SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16412037
Source:
http://linkedlifedata.com/resource/pubmed/id/16412037
Search
Subject
(
63
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0023981
,
umls-concept:C0085104
,
umls-concept:C0087111
,
umls-concept:C0205179
,
umls-concept:C0205187
,
umls-concept:C0206034
,
umls-concept:C0235974
,
umls-concept:C1704259
,
umls-concept:C1705987
pubmed:issue
1
pubmed:dateCreated
2006-1-17
pubmed:abstractText
Evaluate the effect of an implanted percutaneous left subclavian artery port-catheter drug delivery system for regional chemotherapy of inoperable pancreatic carcinoma.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101088612
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic
,
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic
,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil
,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycin
pubmed:status
MEDLINE
pubmed:issn
1443-9611
pubmed:author
pubmed-author:DingJieJ
,
pubmed-author:FanDai MingDM
,
pubmed-author:HanGuo HongGH
,
pubmed-author:HeChuang YeCY
,
pubmed-author:MengXiang JieXJ
,
pubmed-author:SunAn HuaAH
,
pubmed-author:WuKai ChunKC
,
pubmed-author:YinZhan XinZX
,
pubmed-author:ZhangHong BoHB
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
45-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16412037-Adult
,
pubmed-meshheading:16412037-Aged
,
pubmed-meshheading:16412037-Antibiotics, Antineoplastic
,
pubmed-meshheading:16412037-Antimetabolites, Antineoplastic
,
pubmed-meshheading:16412037-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:16412037-Doxorubicin
,
pubmed-meshheading:16412037-Drug Delivery Systems
,
pubmed-meshheading:16412037-Female
,
pubmed-meshheading:16412037-Fluorouracil
,
pubmed-meshheading:16412037-Humans
,
pubmed-meshheading:16412037-Infusions, Intra-Arterial
,
pubmed-meshheading:16412037-Male
,
pubmed-meshheading:16412037-Middle Aged
,
pubmed-meshheading:16412037-Mitomycin
,
pubmed-meshheading:16412037-Neoplasm Staging
,
pubmed-meshheading:16412037-Pancreatic Neoplasms
,
pubmed-meshheading:16412037-Prospective Studies
,
pubmed-meshheading:16412037-Survival Analysis
,
pubmed-meshheading:16412037-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma.
pubmed:affiliation
Institute of Digestive Disease, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Randomized Controlled Trial